Cargando…
Activation of the unfolded protein response in sarcoma cells treated with rapamycin or temsirolimus
Activation of the unfolded protein response (UPR) in eukaryotic cells represents an evolutionarily conserved response to physiological stress. Here, we report that the mTOR inhibitors rapamycin (sirolimus) and structurally related temsirolimus are capable of inducing UPR in sarcoma cells. However, t...
Autores principales: | Briggs, Joseph W., Ren, Ling, Chakrabarti, Kristi R., Tsai, Yien Che, Weissman, Allan M., Hansen, Ryan J., Gustafson, Daniel L., Khan, Yousuf A., Dinman, Jonathan D., Khanna, Chand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5605117/ https://www.ncbi.nlm.nih.gov/pubmed/28926611 http://dx.doi.org/10.1371/journal.pone.0185089 |
Ejemplares similares
-
A Phase I Study of the Combination of Temsirolimus with Irinotecan for Metastatic Sarcoma
por: Verschraegen, Claire F., et al.
Publicado: (2013) -
Differential effects of ketoconazole on exposure to temsirolimus following intravenous infusion of temsirolimus
por: Boni, J P, et al.
Publicado: (2008) -
Ubiquitylation in ERAD: Reversing to Go Forward?
por: Tsai, Yien Che, et al.
Publicado: (2011) -
Evaluating the activity of temsirolimus in neuroendocrine cancer
por: O'Donnell, P H, et al.
Publicado: (2007) -
A randomised phase II trial of selumetinib vs selumetinib plus temsirolimus for soft-tissue sarcomas
por: Eroglu, Z, et al.
Publicado: (2015)